首页 > 最新文献

Acta poloniae pharmaceutica最新文献

英文 中文
Reliable HPLC-UV method for therapeutic levetiracetam monitoring in serum and cerebrospinal fluid of patients with epilepsy 可靠的HPLC-UV法监测癫痫患者血清和脑脊液中左乙拉西坦浓度
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/168230
A. Wesołowska, Elżbieta Szczygieł-Pilut, Łukasz Hońdo, Kinga Wojewodzic, S. Kozłowska, Anna Zajączkowska-Dutkiewicz, Daniel Pilut, M. Michalski, A. Cios
The present study was to develop and validate a rapid analytical method of high-performance liquid chromatography with UV (HPLC/UV) detection for the determination of levetiracetam (LEV) concentration in human serum and cerebrospinal fluid (CSF) samples. The newly developed method was used to measure LEV concentration in the serum/CSF of 29 patients with different types of epilepsy; 52% (group I, n = 15) were treated with LEV in monotherapy, 48% (group II, n = 14) were co-administered with other AEDs. Serum and CSF levels of LEV were correlated with patients dosage, concomitant AEDs, therapeutic effect, and adverse drug reactions (ADRs).The calibration curves for serum and CSF were linear in the range 0.5-100 and 0.5-50 mg/L, respectively, with a coefficient correlation (R) value > 0.998 in each case. The quantitation limit was 0.5 mg/L in serum and CSF. The validated method was found to be selective, precise, and accurate. Optimal Cssmin values according to International League Against Epilepsy (12-46 mg/L) were achieved in 40 and 50% of patients in group I and II, and did not correlate with treatment efficacy in 27 and 21% patients, respectively. The ratio of serum LEV to CSF concentration (Kp) after 2 h administration LEV ranged in group I from 0.31 to 0.92 and in group II from 0.18 to 0.65. These findings indicate that the developed simple and rapid HPLC/UV method may be useful for monitoring serum/CSF LEV concentrations in patients receiving standard doses.
本研究旨在建立高效液相色谱-紫外(HPLC/UV)快速测定人血清和脑脊液(CSF)样品中左乙拉西坦(LEV)浓度的方法。采用新方法测定了29例不同类型癫痫患者血清/脑脊液中LEV浓度;52%(第一组,n = 15)的患者单独使用LEV治疗,48%(第二组,n = 14)的患者与其他AEDs合用。血清和脑脊液LEV水平与患者用药剂量、伴用aed、治疗效果和药物不良反应(adr)相关。血清和脑脊液在0.5 ~ 100 mg/L和0.5 ~ 50 mg/L范围内均呈线性关系,相关系数(R)均为> 0.998。血清和脑脊液的定量限为0.5 mg/L。经验证的方法选择性好、精密度高、准确度高。根据国际抗癫痫联盟(International League Against Epilepsy)的标准,I组和II组中40%和50%的患者达到了最佳的Cssmin值(12-46 mg/L),分别有27%和21%的患者与治疗效果无关。给药2 h后血清LEV与脑脊液浓度之比(Kp) I组为0.31 ~ 0.92,II组为0.18 ~ 0.65。这些结果表明,所建立的简单快速的HPLC/UV方法可用于监测接受标准剂量患者的血清/CSF LEV浓度。
{"title":"Reliable HPLC-UV method for therapeutic levetiracetam monitoring in serum and cerebrospinal fluid of patients with epilepsy","authors":"A. Wesołowska, Elżbieta Szczygieł-Pilut, Łukasz Hońdo, Kinga Wojewodzic, S. Kozłowska, Anna Zajączkowska-Dutkiewicz, Daniel Pilut, M. Michalski, A. Cios","doi":"10.32383/appdr/168230","DOIUrl":"https://doi.org/10.32383/appdr/168230","url":null,"abstract":"The present study was to develop and validate a rapid analytical method of high-performance liquid chromatography with UV (HPLC/UV) detection for the determination of levetiracetam (LEV) concentration in human serum and cerebrospinal fluid (CSF) samples. The newly developed method was used to measure LEV concentration in the serum/CSF of 29 patients with different types of epilepsy; 52% (group I, n = 15) were treated with LEV in monotherapy, 48% (group II, n = 14) were co-administered with other AEDs. Serum and CSF levels of LEV were correlated with patients dosage, concomitant AEDs, therapeutic effect, and adverse drug reactions (ADRs).\u0000The calibration curves for serum and CSF were linear in the range 0.5-100 and 0.5-50 mg/L, respectively, with a coefficient correlation (R) value > 0.998 in each case. The quantitation limit was 0.5 mg/L in serum and CSF. The validated method was found to be selective, precise, and accurate. Optimal Cssmin values according to International League Against Epilepsy (12-46 mg/L) were achieved in 40 and 50% of patients in group I and II, and did not correlate with treatment efficacy in 27 and 21% patients, respectively. The ratio of serum LEV to CSF concentration (Kp) after 2 h administration LEV ranged in group I from 0.31 to 0.92 and in group II from 0.18 to 0.65. These findings indicate that the developed simple and rapid HPLC/UV method may be useful for monitoring serum/CSF LEV concentrations in patients receiving standard doses.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42180535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dispensing metformin with other drugs and dietary supplements in pharmaceutical care in patients with multimorbidity 配药二甲双胍与其他药物和膳食补充剂的药学服务的患者多病
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/168954
L. Żyrek, L. Bułaś, M. Latocha
Pharmaceutical care is an activity aimed at protecting the patient’s health. The purpose of this benefit is to provide assistance in receiving and safely using the drug. The idea of pharmaceutical care originated in the United States in the 70s’ of the 20th century although the issue had already been discussed in the interwar period. The definition in force in Poland is contained in the Act on the Profession of Pharmacist (Act of September 10, 2020). The program includes pharmaceutical consultations, performing medications reviews, developing pharmaceutical care plans considering the patient’s drug-related problems, performing diagnostic tests and issuing prescriptions that are a continuation of a medical order(1).This paper reviews the current literature on the use of metformin in patients with multimorbidity. Special attention was given to the studies on probability of occurrence potential drug-related problems in the treatment of these diseases. The analysis shows that the most difficulties are caused by the lack of knowledge about the treatment used by patients. The result is often a reduction in the regularity of therapy or even resignation from it. The obtained observations related to the combined use of drugs from different therapeutic groups should help to systematize knowledge about the current needs and expectations of patients. Properly conducted pharmaceutical care, including the preparation of drug reviews and education, can significantly improve the effectiveness of treatment. The article emphasizes the importance of the cooperation of the patient, doctor and pharmacist in achieving and maintaining the proper quality of life of the patient.
药物护理是一项旨在保护患者健康的活动。这项福利的目的是为接受和安全使用药物提供帮助。药物护理的概念起源于20世纪70年代的美国,尽管在两次世界大战期间就已经讨论过这个问题。波兰现行的定义载于《药剂师职业法》(2020年9月10日法案)。该计划包括药物咨询、进行药物审查、制定考虑患者药物相关问题的药物护理计划、进行诊断测试和开具作为医嘱延续的处方(1)。本文综述了目前关于二甲双胍在多发病患者中的应用的文献。特别注意对这些疾病治疗中潜在药物相关问题发生概率的研究。分析表明,最困难的原因是缺乏对患者使用的治疗方法的了解。其结果往往是减少治疗的规律性,甚至放弃治疗。所获得的与不同治疗组药物联合使用有关的观察结果应有助于系统化了解患者的当前需求和期望。正确进行药物护理,包括药物审查和教育的准备,可以显著提高治疗的有效性。文章强调了患者、医生和药剂师合作在实现和保持患者适当生活质量方面的重要性。
{"title":"Dispensing metformin with other drugs and dietary supplements in pharmaceutical care in patients with multimorbidity","authors":"L. Żyrek, L. Bułaś, M. Latocha","doi":"10.32383/appdr/168954","DOIUrl":"https://doi.org/10.32383/appdr/168954","url":null,"abstract":"Pharmaceutical care is an activity aimed at protecting the patient’s health. The purpose of this benefit is to provide assistance in receiving and safely using the drug. The idea of pharmaceutical care originated in the United States in the 70s’ of the 20th century although the issue had already been discussed in the interwar period. The definition in force in Poland is contained in the Act on the Profession of Pharmacist (Act of September 10, 2020). The program includes pharmaceutical consultations, performing medications reviews, developing pharmaceutical care plans considering the patient’s drug-related problems, performing diagnostic tests and issuing prescriptions that are a continuation of a medical order(1).\u0000This paper reviews the current literature on the use of metformin in patients with multimorbidity. Special attention was given to the studies on probability of occurrence potential drug-related problems in the treatment of these diseases. The analysis shows that the most difficulties are caused by the lack of knowledge about the treatment used by patients. The result is often a reduction in the regularity of therapy or even resignation from it. The obtained observations related to the combined use of drugs from different therapeutic groups should help to systematize knowledge about the current needs and expectations of patients. Properly conducted pharmaceutical care, including the preparation of drug reviews and education, can significantly improve the effectiveness of treatment. The article emphasizes the importance of the cooperation of the patient, doctor and pharmacist in achieving and maintaining the proper quality of life of the patient.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43791245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DETERMINATION OF RESIDUAL SOLVENTS IN PSMA 11 - AN ACTIVE PHARMACEUTICAL SUBSTANCE IN PSMA-11 KIT FOR Ga-68 LABELLING 用于Ga-68标记的PSMA-11试剂盒中活性药物PSMA-11中残留溶剂的测定
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/168295
R. Lipka, A. Kokoszka, A. Sawicka
A selective, sensitive and low sample consumption GC method for determination of residual solvents in PSMA samples was developed. Selectivity with respect to solvents such as ethanol, diethyl ether, 2-propanole, acetonitrile, dichloromethane, used in manufacturing of PSMA-11, was obtained on two different GC systems and columns. In all these cases, good separation and other system suitability parameters were obtained. The values of detection limit (LOD) and limit of quantitation (LOQ) were estimated and verified experimentally for ethanol, diethyl ether, 2-propanol (IPA), acetonitrile (ACN) and dichloromethane. Full validation parameters i.e.: selectivity, limit of detection (LOD), limit of quantitation (LOQ), linearity, precision, accuracy, robustness and system suitability parameters are presented with respect to ACN and IPA. Accuracy and precision were measured on two GC systems. Statistical tests exhibit, that there are no significant differences in accuracy and precision between two GC systems
建立了一种选择性、灵敏度高、低样品消耗的气相色谱法测定PSMA样品中残留溶剂的方法。在两种不同的气相色谱系统和色谱柱上获得了对制造PSMA-11所用溶剂(如乙醇、乙醚、2-丙醇、乙腈、二氯甲烷)的选择性。在所有这些情况下,获得了良好的分离和其他系统适用性参数。对乙醇、乙醚、2-丙醇(IPA)、乙腈(ACN)和二氯甲烷的检出限(LOD)和定量限(LOQ)进行了估计和实验验证。完整的验证参数,即:选择性,检出限(LOD),定量限(LOQ),线性,精密度,准确度,鲁棒性和系统适用性参数提供了关于ACN和IPA。在两种气相色谱系统上测定了准确度和精密度。统计测试表明,两种GC系统在准确度和精密度上没有显著差异
{"title":"DETERMINATION OF RESIDUAL SOLVENTS IN PSMA 11 - AN ACTIVE PHARMACEUTICAL SUBSTANCE IN PSMA-11 KIT FOR Ga-68 LABELLING","authors":"R. Lipka, A. Kokoszka, A. Sawicka","doi":"10.32383/appdr/168295","DOIUrl":"https://doi.org/10.32383/appdr/168295","url":null,"abstract":"A selective, sensitive and low sample consumption GC method for determination of residual solvents in PSMA samples was developed. Selectivity with respect to solvents such as ethanol, diethyl ether, 2-propanole, acetonitrile, dichloromethane, used in manufacturing of PSMA-11, was obtained on two different GC systems and columns. In all these cases, good separation and other system suitability parameters were obtained. The values of detection limit (LOD) and limit of quantitation (LOQ) were estimated and verified experimentally for ethanol, diethyl ether, 2-propanol (IPA), acetonitrile (ACN) and dichloromethane. Full validation parameters i.e.: selectivity, limit of detection (LOD), limit of quantitation (LOQ), linearity, precision, accuracy, robustness and system suitability parameters are presented with respect to ACN and IPA. Accuracy and precision were measured on two GC systems. Statistical tests exhibit, that there are no significant differences in accuracy and precision between two GC systems","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46289923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HPLC-UV profiles of Cynanchum auricutalaum, Cynanchum bungei and Cynanchum wilfordii and relationships of their antioxidant activities 金秋花、金秋花和金秋花的HPLC-UV谱图及其抗氧化活性的关系
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/163096
Pingsu He, Lingchuan Xu, J. Jin, Junyou Jian, Chunmao Yuan, Wei Gu, X. Hao, Lie-jun Huang
The method for simultaneous determination of the two types of principal components, C21- steroids and acetophenones, in Cynanchum bungei, C. auriculatum and C. wilfordii by high-performance liquid chromatography-ultraviolet (HPLC-UV) was developed for the first time. Under the optimized conditions, good linearities (R2≥0.999) were obtained for all analytes, and relative standard deviations (RSDs) of HPLC-UV method validation ranged from 0.01-1.62%. The results of DPPH (1,1-diphenyl 2-picryl hydrazyl) and ABTS (2,2-azobis-3ethylbenzthiazoline-6-sulfonic acid) free radical scavenging assays indicated that the three species had a significant antioxidant activity, with the half maximal effective concentration (EC50) range of 64.56-593.38 μg/mL. Combined with bivariate analysis, the fingerprint-activity relationship of the offline antioxidant activity of the three species with their fingerprints peak was studied, and the results revealed a dose-effect relationship between acetophenones and antioxidant activity. This study provides a theoretical basis for the correct identification and application of the antioxidant activities of C. auriculatum, C. wilfordii and C. bungei.
本文首次建立了高效液相色谱-紫外(HPLC-UV)同时测定金秋草、金秋草和雷公藤中C21-甾体和苯乙酮两类主成分的方法。在优化条件下,所有分析物均具有良好的线性关系(R2≥0.999),HPLC-UV方法验证的相对标准偏差(rsd)范围为0.01 ~ 1.62%。DPPH(1,1-二苯基- 2-苦硝基肼基)和ABTS(2,2-偶氮-3乙基苯并噻唑-6-磺酸)自由基清除实验结果表明,3种植物均具有显著的抗氧化活性,半数最大有效浓度(EC50)范围为64.56 ~ 593.38 μg/mL。结合双变量分析,研究了三种植物的离线抗氧化活性与指纹峰的指纹-活性关系,结果表明苯乙酮类与抗氧化活性之间存在剂量效应关系。本研究为正确鉴别和应用木耳、雷公藤和黄芪的抗氧化活性提供了理论依据。
{"title":"HPLC-UV profiles of Cynanchum auricutalaum, Cynanchum bungei and Cynanchum wilfordii and relationships of their antioxidant activities","authors":"Pingsu He, Lingchuan Xu, J. Jin, Junyou Jian, Chunmao Yuan, Wei Gu, X. Hao, Lie-jun Huang","doi":"10.32383/appdr/163096","DOIUrl":"https://doi.org/10.32383/appdr/163096","url":null,"abstract":"The method for simultaneous determination of the two types of principal components, C21- steroids and acetophenones, in Cynanchum bungei, C. auriculatum and C. wilfordii by high-performance liquid chromatography-ultraviolet (HPLC-UV) was developed for the first time. Under the optimized conditions, good linearities (R2≥0.999) were obtained for all analytes, and relative standard deviations (RSDs) of HPLC-UV method validation ranged from 0.01-1.62%. The results of DPPH (1,1-diphenyl 2-picryl hydrazyl) and ABTS (2,2-azobis-3ethylbenzthiazoline-6-sulfonic acid) free radical scavenging assays indicated that the three species had a significant antioxidant activity, with the half maximal effective concentration (EC50) range of 64.56-593.38 μg/mL. Combined with bivariate analysis, the fingerprint-activity relationship of the offline antioxidant activity of the three species with their fingerprints peak was studied, and the results revealed a dose-effect relationship between acetophenones and antioxidant activity. This study provides a theoretical basis for the correct identification and application of the antioxidant activities of C. auriculatum, C. wilfordii and C. bungei.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48799802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NK1 receptor binding of a few low molecular weight 3,5-bistrifluoromethylbenzene derivatives 几种与NK1受体结合的低分子量3,5-双三氟甲基苯衍生物
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/163051
Piotr F. J. Lipiński, Joanna Matalińska
We were interested in finding smallest possible ligands of the NK1 receptor (NK1R). Based on structural considerations and molecular docking (scoring) we selected six simple (low molecular weight, MW) 3,5-bistrifluoromethylbenzene derivatives and tested them for human NK1R affinity. The compounds turned out to have detectable but very low affinity for the receptor (IC50 > 100 μM). The discrepancy between the docking scores and the experimental affinity provoked us to perform additional tests of AutoDock Vina scoring function performance against NK1R. The scoring function did not differentiate low MW-low affinity from low MW-high affinity binders, while it underestimated affinity of low MW-high affinity in comparison to high MW-high affinity compounds. The scoring function did not achieve satisfactory performance in discerning low MW-low affinity and low MW-high affinity binders from the sets of decoys. Analysis of molecular dynamics simulation of one of the studied compounds with NK1R suggests that docking might overestimate strength of the H-bond interaction.
我们感兴趣的是寻找最小的NK1受体(NK1R)配体。基于结构考虑和分子对接(评分),我们选择了6个简单的(低分子量,MW) 3,5-双三氟甲基苯衍生物,并测试了它们对人类NK1R的亲和力。结果表明,该化合物对受体具有可检测到的但非常低的亲和力(IC50 ~ 100 μM)。对接评分与实验亲和力之间的差异促使我们对AutoDock Vina评分功能对NK1R的性能进行了额外的测试。评分函数没有区分低mw -低亲和力和低mw -高亲和力的结合物,而与高mw -高亲和力的化合物相比,它低估了低mw -高亲和力的结合物的亲和力。评分函数在区分低毫瓦-低亲和度和低毫瓦-高亲和度粘结剂和诱饵集方面没有达到令人满意的性能。对其中一种化合物与NK1R的分子动力学模拟分析表明,对接可能高估了氢键相互作用的强度。
{"title":"NK1 receptor binding of a few low molecular weight 3,5-bistrifluoromethylbenzene derivatives","authors":"Piotr F. J. Lipiński, Joanna Matalińska","doi":"10.32383/appdr/163051","DOIUrl":"https://doi.org/10.32383/appdr/163051","url":null,"abstract":"We were interested in finding smallest possible ligands of the NK1 receptor (NK1R). Based on structural considerations and molecular docking (scoring) we selected six simple (low molecular weight, MW) 3,5-bistrifluoromethylbenzene derivatives and tested them for human NK1R affinity. The compounds turned out to have detectable but very low affinity for the receptor (IC50 > 100 μM). The discrepancy between the docking scores and the experimental affinity provoked us to perform additional tests of AutoDock Vina scoring function performance against NK1R. The scoring function did not differentiate low MW-low affinity from low MW-high affinity binders, while it underestimated affinity of low MW-high affinity in comparison to high MW-high affinity compounds. The scoring function did not achieve satisfactory performance in discerning low MW-low affinity and low MW-high affinity binders from the sets of decoys. Analysis of molecular dynamics simulation of one of the studied compounds with NK1R suggests that docking might overestimate strength of the H-bond interaction.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45760492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative characteristics of newly diagnosed adult diabetic patients: a pilot study. 新诊断成人糖尿病患者的比较特征:一项初步研究。
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/166473
E. Sokołowska, Halina Car, M. Szelachowska, A. Adamska, N. Wawrusiewicz-Kurylonek, P. Szumowski, Paulina Kossakowska-Malinowska, Diana Bajkowska, B. Podgórska, Marta Wielogórska, Paulina Lisiewicz, Jakub Supronik, A. Popławska-Kita, M. Żendzian-Piotrowska, A. Chabowski, A. Krętowski, K. Siewko
Diabetes is one of the most common chronic diseases. Early and improved classification of the type of diabetes, whether autoimmune (type 1 diabetes mellitus, T1DM, and latent autoimmune diabetes, LADA) or type 2 diabetes mellitus (T2DM), is essential to determine appropriate therapy. We aimed to present the biochemical and immunological characteristics of adult patients with newly diagnosed diabetes without prior drug treatment. This pilot, a cross-sectional study assessed major phenotypic characteristics and antibody titers, including islet cell antibodies (ICA), insulin autoantibodies (IAA), tyrosine phosphatase antibodies (IA-2A), glutamic acid decarboxylase antibodies (GADA), zinc antibodies (ZnT8A), but also selected sphingolipids belongs to ceramides (Cer) and sphingomyelin (SM). A total of 59 participants were included: 21 with T1DM, 15 with T2DM, and 23 with LADA. Saturated fatty acids chain Cer such as Cer-C22:0 and Cer-C24:0 positively correlates with total cholesterol (TC), triglycerides (TC), and low-density lipoprotein cholesterol (LDL), particularly in autoimmune diabetes (LADA, T1DM) while in T2DM group we found a higher frequency of positive correlation only between Cer-C24:0 and TC. In LADA patients, SM-C18:1 and -C:20:4 values rise with increasing fasting and glucagon-stimulated C-peptide values. The prevalence of GADA in patients diagnosed with T1DM is higher in younger patients versus older ones. While patients with LADA were more likely to test positive for multiple (>4) antibodies. In this relatively small cross-sectional study adult patients with newly diagnosed diabetes have fluctuating clinical and metabolic features with variable severity of immune dysfunction, making it easier to diagnose patients.
糖尿病是最常见的慢性疾病之一。早期和改进的糖尿病类型分类,无论是自身免疫性(1型糖尿病,T1DM,潜伏性自身免疫性糖尿病,LADA)还是2型糖尿病(T2DM),对于确定适当的治疗至关重要。我们的目的是了解未经药物治疗的新诊断糖尿病成人患者的生化和免疫学特征。本研究评估了主要表型特征和抗体滴度,包括胰岛细胞抗体(ICA)、胰岛素自身抗体(IAA)、酪氨酸磷酸酶抗体(IA-2A)、谷氨酸脱羧酶抗体(GADA)、锌抗体(ZnT8A),但也选择了属于神经酰胺(Cer)和鞘磷脂(SM)的鞘脂。共纳入59例受试者:21例为T1DM, 15例为T2DM, 23例为LADA。饱和脂肪酸链Cer如Cer- c22:0和Cer- c24:0与总胆固醇(TC)、甘油三酯(TC)和低密度脂蛋白胆固醇(LDL)呈正相关,特别是在自身免疫性糖尿病(LADA、T1DM)中,而在T2DM组中,我们发现只有Cer- c24:0与TC呈正相关的频率更高。在LADA患者中,SM-C18:1和-C:20:4值随着空腹和胰高血糖素刺激的c肽值升高而升高。在诊断为T1DM的患者中,GADA的患病率在年轻患者中高于老年患者。而LADA患者更有可能检测出多种(bbbb4)抗体阳性。在这项相对较小的横断面研究中,新诊断为糖尿病的成年患者具有波动的临床和代谢特征以及不同程度的免疫功能障碍,使患者更容易诊断。
{"title":"Comparative characteristics of newly diagnosed adult diabetic patients: a pilot study.","authors":"E. Sokołowska, Halina Car, M. Szelachowska, A. Adamska, N. Wawrusiewicz-Kurylonek, P. Szumowski, Paulina Kossakowska-Malinowska, Diana Bajkowska, B. Podgórska, Marta Wielogórska, Paulina Lisiewicz, Jakub Supronik, A. Popławska-Kita, M. Żendzian-Piotrowska, A. Chabowski, A. Krętowski, K. Siewko","doi":"10.32383/appdr/166473","DOIUrl":"https://doi.org/10.32383/appdr/166473","url":null,"abstract":"Diabetes is one of the most common chronic diseases. Early and improved classification of the type of diabetes, whether autoimmune (type 1 diabetes mellitus, T1DM, and latent autoimmune diabetes, LADA) or type 2 diabetes mellitus (T2DM), is essential to determine appropriate therapy. We aimed to present the biochemical and immunological characteristics of adult patients with newly diagnosed diabetes without prior drug treatment. This pilot, a cross-sectional study assessed major phenotypic characteristics and antibody titers, including islet cell antibodies (ICA), insulin autoantibodies (IAA), tyrosine phosphatase antibodies (IA-2A), glutamic acid decarboxylase antibodies (GADA), zinc antibodies (ZnT8A), but also selected sphingolipids belongs to ceramides (Cer) and sphingomyelin (SM). A total of 59 participants were included: 21 with T1DM, 15 with T2DM, and 23 with LADA. Saturated fatty acids chain Cer such as Cer-C22:0 and Cer-C24:0 positively correlates with total cholesterol (TC), triglycerides (TC), and low-density lipoprotein cholesterol (LDL), particularly in autoimmune diabetes (LADA, T1DM) while in T2DM group we found a higher frequency of positive correlation only between Cer-C24:0 and TC. In LADA patients, SM-C18:1 and -C:20:4 values rise with increasing fasting and glucagon-stimulated C-peptide values. The prevalence of GADA in patients diagnosed with T1DM is higher in younger patients versus older ones. While patients with LADA were more likely to test positive for multiple (>4) antibodies. In this relatively small cross-sectional study adult patients with newly diagnosed diabetes have fluctuating clinical and metabolic features with variable severity of immune dysfunction, making it easier to diagnose patients.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45821999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-fatigue effect of ferulic acid in exercise trained mice 阿魏酸对运动训练小鼠的抗疲劳作用
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/165778
Xianchu Liu, Ming-xue Liu
Ferulic acid (FA) was proved to have various pharmacological characteristics in muscle function. Fatigue is closely linked with muscle dysfunction. However, the correlation between fatigue and FA is unclear. Hence, our aim was to appraise anti-fatigue property of FA in exercise trained mice. Our results displayed FA enhanced exhaustion time and grip strength to postpone fatigue. In excessive exercise, FA reduced serum CK, LDH, ALT and AST levels to protect against liver and muscle damage. In liver and muscle, FA improved glycogen contents to increase substance of energy source. In skeletal muscle, FA restrained oxidative stress by accelerating SOD, CAT and GSH-PX activites, and mitigating MDA level. Moreover, FA also attenuated inflammatory response by decreasing TNF-a and IL-6 levels. Lastly, FA ameliorated energy metabolism by increasing Na+-K+-ATPase and SDH activities. In conclusion, FA protected against excessive exercise-fatigue through improvement of energy supply, oxidative stress, inflammatory response and energy metabolism-correlated enzymes.
阿魏酸(FA)已被证明在肌肉功能中具有多种药理特性。疲劳与肌肉功能障碍密切相关。然而,疲劳和FA之间的关系尚不清楚。因此,我们的目的是评价FA在运动训练小鼠中的抗疲劳性能。我们的研究结果显示,FA增加了疲劳时间和握力,以延缓疲劳。在过度运动中,FA降低血清CK、LDH、ALT和AST水平,保护肝脏和肌肉免受损伤。在肝脏和肌肉中,FA提高了糖原含量,增加了能量来源物质。在骨骼肌中,FA通过促进SOD、CAT和GSH-PX活性以及降低MDA水平来抑制氧化应激。此外,FA还通过降低TNF-a和IL-6水平来减轻炎症反应。最后,FA通过增加Na+-K+- atp酶和SDH活性来改善能量代谢。综上所述,FA通过改善能量供应、氧化应激、炎症反应和能量代谢相关酶来防止过度运动性疲劳。
{"title":"Anti-fatigue effect of ferulic acid in exercise trained mice","authors":"Xianchu Liu, Ming-xue Liu","doi":"10.32383/appdr/165778","DOIUrl":"https://doi.org/10.32383/appdr/165778","url":null,"abstract":"Ferulic acid (FA) was proved to have various pharmacological characteristics in muscle function. Fatigue is closely linked with muscle dysfunction. However, the correlation between fatigue and FA is unclear. Hence, our aim was to appraise anti-fatigue property of FA in exercise trained mice. Our results displayed FA enhanced exhaustion time and grip strength to postpone fatigue. In excessive exercise, FA reduced serum CK, LDH, ALT and AST levels to protect against liver and muscle damage. In liver and muscle, FA improved glycogen contents to increase substance of energy source. In skeletal muscle, FA restrained oxidative stress by accelerating SOD, CAT and GSH-PX activites, and mitigating MDA level. Moreover, FA also attenuated inflammatory response by decreasing TNF-a and IL-6 levels. Lastly, FA ameliorated energy metabolism by increasing Na+-K+-ATPase and SDH activities. In conclusion, FA protected against excessive exercise-fatigue through improvement of energy supply, oxidative stress, inflammatory response and energy metabolism-correlated enzymes.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48951503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic antihyperglycemic effect of alpha lipoic acid with antidiabetic agents in the normoglycemic and streptozotocin-induced type 2 diabetic rats 硫辛酸与降糖药对正常血糖及链霉素诱导的2型糖尿病大鼠的协同降糖作用
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/166047
Rawsan Ali Sabri, B. Hameed, Falah Hassen Shari
The current study's main goal was to assess the supplementation effect of alpha lipoic acid with antidiabetic medications (metformin and sitagliptin) on normal and streptozotocin-induced blood glucose levels in normal and streptozotocin-induced diabetic rats. For this purpose, forty-two rats were randomly divided into two groups: normal control (n = 6) and diabetic (n = 36) groups, which were submitted to the following treatments: A: normal rats; B: diabetic rats; C: diabetic rats with sitagliptin (1 mg/kg); D: diabetic rats with metformin (10 mg/kg); E: diabetic rats with alpha lipoic acid (10 mg/kg); F: diabetic rats with a combination of alpha lipoic acid and sitagliptin; G: diabetic rats with a combination of alpha lipoic acid and metformin. The glycemia of these animals was monitored weekly; the use of alpha lipoic acid resulted in a significant decrease in glycemic levels. Combining alpha lipoic acid with either metformin or sitagliptin is most effective for reducing blood glucose levels in animals with acute and chronic hyperglycemia, even at different treatment times. Thus, associated with either metformin or sitagliptin, alpha lipoic acid improved their anti-diabetic effects.
当前研究的主要目的是评估α硫辛酸与降糖药物(二甲双胍和西格列汀)对正常和链脲佐菌素诱导的糖尿病大鼠血糖水平的补充作用。为此,将42只大鼠随机分为正常对照组(n = 6)和糖尿病组(n = 36),分别进行如下处理:A:正常大鼠;B:糖尿病大鼠;C:糖尿病大鼠西格列汀(1mg /kg);D:糖尿病大鼠给予二甲双胍(10 mg/kg);E:糖尿病大鼠α硫辛酸(10 mg/kg);F: α硫辛酸联合西格列汀治疗糖尿病大鼠;G:糖尿病大鼠与α硫辛酸和二甲双胍的组合。每周监测这些动物的血糖;硫辛酸的使用导致血糖水平显著下降。α硫辛酸与二甲双胍或西格列汀联合使用对降低急性和慢性高血糖动物的血糖水平最有效,即使在不同的治疗时间。因此,与二甲双胍或西格列汀联合使用,α硫辛酸可改善其抗糖尿病作用。
{"title":"Synergistic antihyperglycemic effect of alpha lipoic acid with antidiabetic agents in the normoglycemic and streptozotocin-induced type 2 diabetic rats","authors":"Rawsan Ali Sabri, B. Hameed, Falah Hassen Shari","doi":"10.32383/appdr/166047","DOIUrl":"https://doi.org/10.32383/appdr/166047","url":null,"abstract":"The current study's main goal was to assess the supplementation effect of alpha lipoic acid with antidiabetic medications (metformin and sitagliptin) on normal and streptozotocin-induced blood glucose levels in normal and streptozotocin-induced diabetic rats. For this purpose, forty-two rats were randomly divided into two groups: normal control (n = 6) and diabetic (n = 36) groups, which were submitted to the following treatments: A: normal rats; B: diabetic rats; C: diabetic rats with sitagliptin (1 mg/kg); D: diabetic rats with metformin (10 mg/kg); E: diabetic rats with alpha lipoic acid (10 mg/kg); F: diabetic rats with a combination of alpha lipoic acid and sitagliptin; G: diabetic rats with a combination of alpha lipoic acid and metformin. The glycemia of these animals was monitored weekly; the use of alpha lipoic acid resulted in a significant decrease in glycemic levels. Combining alpha lipoic acid with either metformin or sitagliptin is most effective for reducing blood glucose levels in animals with acute and chronic hyperglycemia, even at different treatment times. Thus, associated with either metformin or sitagliptin, alpha lipoic acid improved their anti-diabetic effects.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43568665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of women's eating behaviours in home isolation due to COVID-19 in the context of the dietary impact on the course of the disease 在饮食对疾病病程影响的背景下,分析因COVID-19而居家隔离的女性饮食行为
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-28 DOI: 10.32383/appdr/168231
Paulina Górska, Ilona Górna, I. Miechowicz, J. Przysławski
The aim of the study was to collect and analyse data on people's eating behaviours and physical activity in home isolation due to a SARS-CoV-2 infection. In addition, the purpose of the study was to show how taste and smell disturbance can affect eating behaviours. Identifying dietary mistakes and then making recommendations to patients within that scope could help avoid a severe COVID-19 infection and speed up recovery. An anonymous online survey was conducted to study the dietary behavior and physical activity levels of COVID-19 sufferers between April and August 2022. The research tool comprised a specially devised and structured questionnaire and the FFQ-D10 food frequency questionnaire. A total of 159 people completed the questionnaire. Out of that number, 153 women over 18 years of age who were in home isolation due to COVID-19 were included in the study. The results show that 1.133 portions of cereal products were consumed daily, with unrefined groats and wholemeal or 'brown' bread with seeds being more common. Vegetable consumption stood at 2.225 portions per day, and fresh fruit at 1.774 portions per day. For sweets, consumption was 0.511 portions per day. Products that the study participants were least likely to consume were sweetened drinks, red meat, conventionally sweetened sweet fruit preserves, dried fruit and sweetened dairy drinks. Analysis of the anthropometric characteristics and dietary behaviour of women who participated in the study allowed for the preparation of dietary recommendations for COVID-19 patients.
这项研究的目的是收集和分析由于严重急性呼吸系统综合征冠状病毒2型感染而在家隔离期间人们的饮食行为和身体活动数据。此外,这项研究的目的是展示味觉和嗅觉障碍如何影响饮食行为。识别饮食错误,然后向该范围内的患者提出建议,可以帮助避免严重的新冠肺炎感染并加快康复。进行了一项匿名在线调查,以研究2022年4月至8月期间新冠肺炎患者的饮食行为和体育活动水平。该研究工具包括一份专门设计和结构化的问卷和FFQ-D10食物频率问卷。共有159人完成了问卷调查。在这一数字中,有153名18岁以上的女性因新冠肺炎而被纳入研究。结果显示,每天摄入1.133份谷物产品,其中未精制的燕麦和全麦或带籽的“棕色”面包更为常见。蔬菜消费量为每天2.225份,新鲜水果为每天1.774份。糖果的摄入量为每天0.511份。研究参与者最不可能消费的产品是加糖饮料、红肉、传统的加糖甜水果蜜饯、干果和加糖乳制品饮料。通过对参与研究的女性的人体测量特征和饮食行为进行分析,可以为新冠肺炎患者制定饮食建议。
{"title":"Analysis of women's eating behaviours in home isolation due to COVID-19 in the context of the dietary impact on the course of the disease","authors":"Paulina Górska, Ilona Górna, I. Miechowicz, J. Przysławski","doi":"10.32383/appdr/168231","DOIUrl":"https://doi.org/10.32383/appdr/168231","url":null,"abstract":"The aim of the study was to collect and analyse data on people's eating behaviours and physical activity in home isolation due to a SARS-CoV-2 infection. In addition, the purpose of the study was to show how taste and smell disturbance can affect eating behaviours. Identifying dietary mistakes and then making recommendations to patients within that scope could help avoid a severe COVID-19 infection and speed up recovery. An anonymous online survey was conducted to study the dietary behavior and physical activity levels of COVID-19 sufferers between April and August 2022. The research tool comprised a specially devised and structured questionnaire and the FFQ-D10 food frequency questionnaire. A total of 159 people completed the questionnaire. Out of that number, 153 women over 18 years of age who were in home isolation due to COVID-19 were included in the study. The results show that 1.133 portions of cereal products were consumed daily, with unrefined groats and wholemeal or 'brown' bread with seeds being more common. Vegetable consumption stood at 2.225 portions per day, and fresh fruit at 1.774 portions per day. For sweets, consumption was 0.511 portions per day. Products that the study participants were least likely to consume were sweetened drinks, red meat, conventionally sweetened sweet fruit preserves, dried fruit and sweetened dairy drinks. Analysis of the anthropometric characteristics and dietary behaviour of women who participated in the study allowed for the preparation of dietary recommendations for COVID-19 patients.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47685172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of intravitreal injection of amikacin for endophthalmitis: a systematic review 玻璃体内注射阿米卡星治疗眼内炎的疗效和安全性:一项系统综述
IF 0.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-20 DOI: 10.32383/appdr/163452
Zichao Ji, Yue-Ping Xie, Xin Wang, Guang-Yao Li, Chao Zhang
The aim of this study was to evaluate the efficacy and safety of intravitreal injection of amikacin in the treatment of endophthalmitis, and to provide reference for clinical decision making, registered (PROSPERO-CRD42022300395) and performed according PRISMA. PubMed, EMbase, The Cochrane Library, ClinicalTrials.gov, CNKI and Wanfang database were searched by computer to collect clinical studies on the efficacy and safety of intravitreal amikacin in the treatment of endophthalmitis. The retrieval period is from database construction to June 20, 2022. Two evaluators independently screened the literature according to the inclusion and exclusion criteria, extracted the data and evaluated the quality. Then qualitative analysis was used to describe the results. Finally, 5 case series studies were included, and the disease was exogenous endophthalmitis. A total of 115 patients and 115 eyes were included, with 11 to 39 patients in each study, 36.84% to 85.71% males and 30.4 to 60.7 years old on average. Follow-up was 6 weeks to 12 months. The study intervention of intravitreal vancomycin and amikacin improved visual acuity after combined therapy. In the 5 studies included in this study, no intraocular or systemic systemic adverse reactions were reported for intravitreal injection of amikacin. It was found that patients with exogenous endophthalmitis, including after surgery or ocular trauma, intravitreal injection of amikacin in combination with vancomycin is recommended for empiric treatment. However, high-quality randomized controlled trials or cohort studies are needed to verify this.
本研究的目的是评估玻璃体内注射阿米卡星治疗眼内炎的有效性和安全性,并为临床决策提供参考,注册(PROSPERO-CRD42022300395)并根据PRISMA进行。通过计算机检索PubMed、EMbase、The Cochrane Library、ClinicalTrials.gov、CNKI和万方数据库,收集玻璃体内阿米卡星治疗眼内炎的疗效和安全性的临床研究。检索期为数据库建设至2022年6月20日。两名评估人员根据纳入和排除标准对文献进行独立筛选,提取数据并评估质量。然后使用定性分析来描述结果。最后,纳入了5个病例系列研究,该疾病为外源性眼内炎。共纳入115名患者和115只眼睛,每个研究中有11至39名患者,36.84%至85.71%为男性,平均年龄30.4至60.7岁。随访时间为6周到12个月。玻璃体内万古霉素和阿米卡星的研究干预改善了联合治疗后的视力。在本研究的5项研究中,未报告玻璃体内注射阿米卡星的眼内或全身性不良反应。研究发现,外源性眼内炎患者,包括手术后或眼部创伤后,建议玻璃体内注射阿米卡星联合万古霉素进行经验性治疗。然而,需要高质量的随机对照试验或队列研究来验证这一点。
{"title":"Efficacy and safety of intravitreal injection of amikacin for endophthalmitis: a systematic review","authors":"Zichao Ji, Yue-Ping Xie, Xin Wang, Guang-Yao Li, Chao Zhang","doi":"10.32383/appdr/163452","DOIUrl":"https://doi.org/10.32383/appdr/163452","url":null,"abstract":"The aim of this study was to evaluate the efficacy and safety of intravitreal injection of amikacin in the treatment of endophthalmitis, and to provide reference for clinical decision making, registered (PROSPERO-CRD42022300395) and performed according PRISMA. PubMed, EMbase, The Cochrane Library, ClinicalTrials.gov, CNKI and Wanfang database were searched by computer to collect clinical studies on the efficacy and safety of intravitreal amikacin in the treatment of endophthalmitis. The retrieval period is from database construction to June 20, 2022. Two evaluators independently screened the literature according to the inclusion and exclusion criteria, extracted the data and evaluated the quality. Then qualitative analysis was used to describe the results. Finally, 5 case series studies were included, and the disease was exogenous endophthalmitis. A total of 115 patients and 115 eyes were included, with 11 to 39 patients in each study, 36.84% to 85.71% males and 30.4 to 60.7 years old on average. Follow-up was 6 weeks to 12 months. The study intervention of intravitreal vancomycin and amikacin improved visual acuity after combined therapy. In the 5 studies included in this study, no intraocular or systemic systemic adverse reactions were reported for intravitreal injection of amikacin. It was found that patients with exogenous endophthalmitis, including after surgery or ocular trauma, intravitreal injection of amikacin in combination with vancomycin is recommended for empiric treatment. However, high-quality randomized controlled trials or cohort studies are needed to verify this.","PeriodicalId":7147,"journal":{"name":"Acta poloniae pharmaceutica","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46209526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta poloniae pharmaceutica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1